35592504|t|miR-23b-3p rescues cognition in Alzheimer's disease by reducing tau phosphorylation and apoptosis via GSK-3beta signaling pathways.
35592504|a|Dysregulated microRNA (miRNA) expression in the brain can contribute to cognitive dysfunction and aberrant tau hyperphosphorylation in Alzheimer's disease (AD). Several studies have reported a role for microRNA-23b-3p (miR-23b-3p) in various neurologic disorders; however, its involvement in cognition-related functions remains unclear. In the present study, we investigated the potential therapeutic effects and mechanisms of miR-23b-3p in AD. miRNA profiles in the cortex of amyloid precursor protein (APP)/presenilin 1 (PS1) double transgenic mice (APP/PS1 mice) demonstrated that miR-23b-3p was reduced. This decrease was verified in APPswe cells, SAMP8 mouse brains, and plasma from AD patients. Furthermore, glycogen synthase kinase-3beta (GSK-3beta), a major tau kinase implicated in tau pathology, was identified as a target of miR-23b-3p. Functional in vivo studies demonstrated that intracerebroventricular delivery of miR-23b-3p in APP/PS1 mice ameliorated cognitive deficits, histopathological changes, and tau phosphorylation immunoreactivity at several sites by inhibiting GSK-3beta expression and activation. Similarly, the upregulation of miR-23b-3p in APPswe cells inhibited GSK-3beta-mediated tau hyperphosphorylation, Abeta1-42 generation, and neuronal apoptosis, resulting in the suppression of the GSK-3beta/p-tau and Bax/caspase-3 pathways. Collectively, our findings strongly support the hypothesis that miR-23b-3p plays a neuroprotective role in AD, thereby identifying miR-23b-3p as a promising therapeutic target for AD.
35592504	32	51	Alzheimer's disease	Disease	MESH:D000544
35592504	102	111	GSK-3beta	Gene	56637
35592504	204	225	cognitive dysfunction	Disease	MESH:D003072
35592504	267	286	Alzheimer's disease	Disease	MESH:D000544
35592504	288	290	AD	Disease	MESH:D000544
35592504	374	394	neurologic disorders	Disease	MESH:D009461
35592504	573	575	AD	Disease	MESH:D000544
35592504	609	634	amyloid precursor protein	Gene	11820
35592504	641	653	presenilin 1	Gene	19164
35592504	655	658	PS1	Gene	19164
35592504	678	682	mice	Species	10090
35592504	688	691	PS1	Gene	19164
35592504	692	696	mice	Species	10090
35592504	770	776	APPswe	CellLine	CVCL:D650
35592504	784	789	SAMP8	CellLine	CVCL:4564
35592504	790	795	mouse	Species	10090
35592504	820	822	AD	Disease	MESH:D000544
35592504	823	831	patients	Species	9606
35592504	846	876	glycogen synthase kinase-3beta	Gene	56637
35592504	878	887	GSK-3beta	Gene	56637
35592504	976	978	3p	Chromosome	3
35592504	1079	1082	PS1	Gene	19164
35592504	1083	1087	mice	Species	10090
35592504	1100	1118	cognitive deficits	Disease	MESH:D003072
35592504	1219	1228	GSK-3beta	Gene	56637
35592504	1301	1307	APPswe	CellLine	CVCL:D650
35592504	1324	1333	GSK-3beta	Gene	56637
35592504	1395	1413	neuronal apoptosis	Disease	MESH:D065703
35592504	1451	1460	GSK-3beta	Gene	56637
35592504	1471	1474	Bax	Gene	12028
35592504	1475	1484	caspase-3	Gene	12367
35592504	1602	1604	AD	Disease	MESH:D000544
35592504	1675	1677	AD	Disease	MESH:D000544
35592504	Association	MESH:D003072	56637
35592504	Association	MESH:D065703	12367
35592504	Association	MESH:D065703	56637

